1. Home
  2. FA vs TWST Comparison

FA vs TWST Comparison

Compare FA & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$15.84

Market Cap

2.6B

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$74.40

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
TWST
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FA
TWST
Price
$15.84
$74.40
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$15.67
$46.88
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
63.89
EPS
0.01
N/A
Revenue
$1,574,389,000.00
$376,572,000.00
Revenue This Year
$8.42
$18.91
Revenue Next Year
$7.26
$15.07
P/E Ratio
$1,577.00
N/A
Revenue Growth
83.02
20.32
52 Week Low
$8.82
$23.30
52 Week High
$19.01
$80.50

Technical Indicators

Market Signals
Indicator
FA
TWST
Relative Strength Index (RSI) 59.09 73.74
Support Level $15.63 $41.85
Resistance Level $16.19 N/A
Average True Range (ATR) 0.69 4.84
MACD -0.03 1.71
Stochastic Oscillator 52.72 84.06

Price Performance

Historical Comparison
FA
TWST

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: